A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

Conditions: Refractory Chronic Cough Interventions: Drug: TCR1672 tablet Sponsors: Beijing Tide Pharmaceutical Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cough | Research | Study